MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchCrypto SummaryFAQAbout
Medical Laboratories Stocks$115.00
0.47%4:00PM 05/26/2023
The list of companies include BIOC-Biocept Inc, CDNA-Caredx Inc, CELC-Celcuity Inc, NTRA-Natera Inc, NVTA-Invitae Corp, OPGN-Opgen Inc, PSNL-Personalis Inc, VCYT-Veracyte Inc, WST-West Pharmaceutical Services, Inc.
Latest intraday update before market close @ 19:45:46 PM 05/26/2023
Summary :
Average return is up 0.3%
Median return is down -0.2%
3 out of 7 stocks are up (limited to those with intraday pricing feeds).

Aggregated price index

Aggregated price index with volume information

Summary:

  • Medical Laboratories stocks up 0.5% on average while median return up 0.4% in a day
  • Medical Laboratories stocks up 0.7% on average while median return up -1.9% in a week
  • Medical Laboratories stocks down 4.3% on average while median return down 3.2% in a month
  • When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.

Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.

Related Stocks

Click on + to show price series and click on ticker for stock detail page

Ticker
1 Day Return
1 Week Return
1 Month Return
PE Ratio
PE/G
P/B (mrq)
P/S (ttm)
Earning Growth
MarketCap
Short %
Held By Institutions %
RSI
Price Pattern
Resist Support
Days Since Channel Change
Channel Slope (daily rate %)
CELC5.1%
6.5%
7.3%
-0.549.10235.6M7%25%59\/\82-0.1%
WST1.0%
-2.2%
-3.3%
47.121.7514.2111.18103%25.5B2%95%39/\/1760.2%
OPGN0.9%
-6.2%
-22.4%
1.8519.284.3M1%7%38\71-1.2%
NTRA0.8%
-4.2%
-3.2%
-9.1324.1520.145.6B8%101%41/\/1760.2%
VCYT0.4%
4.9%
14.8%
2.5920.481.9B7%106%60/\/1760.2%
PSNL-0.5%
-11.1%
-15.4%
-0.780.796.8913.4690.3M9%87%38/\-176-0.1%
CDNA-1.6%
3.6%
2.3%
15.769.7620.86428.2M11%101%44/\176-0.3%
NVTA-1.9%
-1.9%
-22.1%
-0.08-1.92.7320.54276.3M16%82%37/-\176-0.3%

* P/E and MarketCap are refreshed daily using IEX Cloud service. P/B, P/S, PEG, growth, short%, HelbyInstitute are refreshed weekly using Yahoo feeds. For latest stock stats please visit Yahoo Finance.

* Price Patter: / is upward trend, \ is downward trend, - is sideway. Click on the ticker to go to stock page to see Bayesian Trend model plot of the time series.

* Channel and change points are derived from Bayesian Trend model, where the channel slope is the growth rate while change points are those the model partition the time series.

Related ETFs (click on ticker for stock detail page)

leak data

  • 1M winners are : Winners for past month are $VCYT 14.8%, $CELC 7.3%, $CDNA 2.3%
  • 1M losers are : Losers for past month are $WST -3.3%, $PSNL -15.4%, $NVTA -22.1%
  • 1W winners are : Winners for past week are $CELC 6.5%, $VCYT 4.9%, $CDNA 3.6%
  • 1W losers are : Losers for past week are $WST -2.2%, $NTRA -4.2%, $PSNL -11.1%
Pick two stocks to compare:

Correlation Analysis

Index correlation analysis

Correlation for the past month is 24.6%, for the past 3 months is 16.8%

In the past month for a 5 days rolling window, the highest corrrelation is 44.4%, the lowest correlation is -5.4%, the latest correlation is 36.8%

When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.

Among pairwise correlation, the highest correlation is 68.9% between CDNA and VCYT

The lowest correlation is -22.2% between PSNL and WST

Stock news

    05/24/2023CELC
    Celcuity to Participate in Upcoming Craig-Hallum and Jefferies Investor Conferences

    / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced that Brian Sullivan, Chairman, Chief Executive Officer, and Co-founder of Celcuity, will participate in the following investor conferences:

    05/24/2023CELC
    Insiders of Celcuity Getting Good Value On Their US$1.6m Investment \

    Last week, Celcuity Inc. ( NASDAQ:CELC ) insiders, who had purchased shares in the previous 12 months were rewarded...

    05/19/2023ANPC
    Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES'

    Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, today announced that its ticker symbol on the Nasdaq Stock Market ("Nasdaq") will change to "FRES" effective at the open of market trading on May 22, 2023 following the Compa

    05/19/2023WST
    Here's Why You Should Retain Glaukos (GKOS) in Your Portfolio

    Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.

    05/16/2023ANPC
    Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022

    Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd., "Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2022, with the U.S. Securities and Exchange

    05/16/2023ANPC
    Fresh2 Reports Fiscal Year 2022 Annual Financial Results

    Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd. ,"Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, announced today its annual financial results for the year ended December 31, 2022.

    05/16/2023ANPC
    Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results

    Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd., "Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, announced today its unaudited financial results for the first quarter ended March 31, 2023. The Company's financial statements and related fina

    05/16/2023PSNL
    Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer

    FREMONT, Calif. & KASHIWA, Japan & OSAKA, Japan, May 16, 2023--Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer

    05/16/2023CDNA
    CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management Forum

    BRISBANE, Calif., May 16, 2023--CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it will showcase its digital health portfolio and host a symposium which addresses barriers in access to transplantation at the 31st Annual UNOS Transplant Management Forum (TMF) taking place May 16-18 in Denver, Colo

    05/16/2023CDNA
    Should You Exit CareDx (CDNA)?

    Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. The fund was up 11.20% in the first quarter compared to the Russell 2000 Growth Index’s return of 6.07%. The strong performance of holdings in the Information Technology (IT), Industrials, and […]